Severity scoring of atopic dermatitis: A comparison of two scoring systems

Allergologia et Immunopathologia

Volumn 36, Issue 4, 2008, Pages 205-211

  Rullo, Vera E V ^a,b   Segato, A ^a   Kirsh, A ^a   Sole, D ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Atopic dermatitis; Score; Scoring system; Severity

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; FLUTICASONE; HYDROXYZINE; MOMETASONE FUROATE; STEROID;

ARTICLE; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DISEASE SEVERITY; HUMAN; INFANT; INFANT DISEASE; PATIENT MONITORING; SCORING SYSTEM; SKIN ALLERGY; TREATMENT OUTCOME;

EID: 55049108621     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1157/13127044     Document Type: Article

References (20)

1. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis - a prospective follow-up to 7 years of age. Allergy. 2000;55:240-245.
2. Illi S, von Mutius E, Lau S, Nickel R, Grüber C MD, Niggemann B et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma J Allergy Clin Immunol 2004;113:925-931.
3. Pucci N, Lombardi E, Novembre E, Farina S, Bernardini R, Rossi ME et al. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. J Allergy Clin Immunol. 2000;105:353-7.
4. Ricci G, Bendandi B, Bellini F, Patrizi A, Masi M. Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score. Pediatr Allergy Immunol. 2007;18:245-50.
5. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993;186:23-31.
6. Berth-Jones J. Six Area, Six Sign Atopic Dermatitis (SASSAD), Severity Score; a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol. 1996;135 Suppl. 48:25-30.
7. Costa C, Rilliet A, Nicolet M, Saurat JH. Scoring atopic dermatitis: the simpler the better? Acta Derm Venereol (Stockh) 1989;69:41-5.
8. Bahmer FA, Schaefer J, Schubert HJ. Quantification of the extent and the severity of atopic dermatitis; the ADASI score. (Letter.) Arch Dermatol 1991;127:1239-40.
9. Jochen Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol. 2007;120:1389-98.
10. Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol. 2007;120:1389-98.
11. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M, the EASI Evaluator Group. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol. 2001;10:11-18.
12. Pucci N, Lombardi E, Novembre E, Farina S, Bernardini R, Rossi ME et al. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. J Allergy Clin Immunol. 2000;105:353-7.
13. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001; 10:11-8.
14. Sprikkelman AB, Tupker RA, Burgerhof H, Schouten JP, Brand PLP, Heymans HAS et al. Severity scoring of atopic dermatitis: a comparison of three scoring systems. Allergy 1997;52:944-49.
15. Hanifin JM, Ling MR, Langley R, Breneman D, Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, Efficacy. J Am Acad Dermatol. 2001;44:S28-S38.
16. Kang S, Lucky A, Pariser D, Lawrence I, Hanifin J, and the Tacrolimus Ointment Study Group. A long-term, noncomparative trial to evaluate the safety of topically applied tacrolimus as treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol. 2001;44:S58-S64.
17. Paller A, Eichenfield L F, Leung D, Stewart D, Appell M. Topically applied tacrolimus ointment vs. vehicle ointment in pediatric patients with atopic dermatitis. J Am Acad Dermatol. 2001;44:S47-S57.
18. Bieber T, Vick K, Folster-Holst R, Belloni-Fortina A, Stodtler G, Worm M et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1 % compared to tacrolimus 0.03 % in children and adolescents with an acute flare of severe atopic dermatitis. Allergy. 2007;62:184-9.
19. Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatology. 2006;155:680-7.
20. Charman CR, Venn AJ, Williams HC. Measurement of body surface area involvement in atopic eczema: an impossible task? Br J Dermatology. 1999;140:109-11.